Clinical trial NCT05776368: Links Between Motor Abilities and Language Ability Deficits in Patients With Post-stroke Aphasia
Official title: Links Between Motor Abilities and Language Ability Deficits in Patients With Post-stroke Aphasia
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Stroke
Aphasia
Keywords: stroke
aphasia
rehabilitation
tool use
Broca's area
basal ganglia
healthy volunteer
language and motor abilities
Lead sponsor: Hospices Civils de Lyon
Sponsor class: OTHER
First posted: 2023-03-20
Enrollment: 360
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: BASIC_SCIENCE

Brief summary: Aphasia is a language disorder that affects oral and written expression and/or comprehension. It's one of the most disabling consequence of stroke. Nowadays, aphasia rehabilitation is supported by speech therapists and is based on oral and written language, comprehension and expression. However recent studies have shown links between language and motor function (especially tool use). Two domains that share neural substrates (Broca's area, basal ganglia) and that can influence each other.

The aim of this study is to show that a motor training with a tool (pliers) can improve short-term and long-term language abilities of aphasic patients who had a stroke at least 3 months ago.

The investigators hypothesis is that there is a learning transfer between tool use and language abilities in aphasic patients with an inferior frontal gyrus (IFG) lesion caused by a stroke, thanks to their shared neural resources.

Investigators aim to study long and short-time effects of this tool motor training with three experiments:

* E1 will study short-term effects by estimating pre-post effect of a motor training on language abilities. Investigators will experiment different effectors: tool, hand, none (control group); on patients and healthy volunteers.
* E2 will study long-term effects with multiple single-case experimental designs (SCED). Patients will undergo four weeks of on-off design.
* E3 will study long-term effects by estimating the efficiency of an experimental sensorimotor protocol of four weeks, comparing a group of patients with the experimental sensorimotor protocol to a control group of patients


Eligibility criteria: Inclusion Criteria:

For all participants:

* Adult male or female aged 18 years and over
* Right-handed
* Having signed an informed and written consent
* Affiliated to a social security scheme
* Have French as their first language

For patients :

* Left inferior frontal gyrus lesion following a stroke
* Stroke more than 3 months old
* Aphasia proven by a pathological score on the A-2 test of the Syntax Comprehension Battery (BCS)

Exclusion Criteria:

For all participants:

* Cognitive abilities that prevent completion of the study tasks (assessed with the MOntreal Cognitive Assesment (MOCA))
* Language skills impaired by other disorders (for example neurodegenerative disease)
* Cognitive impairing treatments (for example psychotropic drugs)
* Neurovisual disorder (hemineglect, unilateral spatial neglect)
* Impairment of both upper limb abilities that prevent motor training (pathological score in the Purdue Pegboard Test and/or Box and Block Test).
* Recurrence of a stroke impacting the reorganisation of neural networks
* Persons deprived of their liberty by a judicial or administrative decision Persons of legal age under a legal protection measure (guardianship, curatorship)
* Pregnant women, women in labour or nursing mothers, confirmed by questioning the participant
* Participation in another study at the same time as this one

Primary outcomes:
measure: reaction time
timeFrame: 4 weeks following the inclusion
measure: sensitivity index
timeFrame: 4 weeks following the inclusion
Secondary outcomes:
measure: number of inserted pieces
timeFrame: 4 weeks following the inclusion
Other outcomes:
Locations:
city: Bron Cedex
country: France
facility: Equipe ImpAct CRNL
city: Bron
country: France
facility: Hôpital neurologique Pierre Wertheimer
city: Saint-Genis-Laval
country: France
facility: Hôpital Henry Gabrielle
Study officials:
References: